Skip to content

CD137 ACI3201B

by Biocare Medical, LLC

CD137 ACI3201B is a tumour necrosis factor receptor superfamily IVD (FDA Class I; FDA product code NJT, Immunohistochemistry Reagents And Kits) made by Biocare Medical, LLC, listed in FDA GUDID since 7 Dec 2022 (UDI-DI 00847627003591), registry data as of 23 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00847627003591 UDI-DI Date7 Dec 2022ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
CD137
Generic name
Tumour necrosis factor receptor superfamily IVD, antibody
Model / reference
ACI3201B
Primary DI / UDI-DI
00847627003591
FDA product code
NJT
GMDN term
Tumour necrosis factor receptor superfamily IVD, antibody
Device class
Class I
Regulation number
864.1860
GUDID distribution status
In Commercial Distribution

Similar devices in this category

Other devices filed under Tumour necrosis factor receptor superfamily IVD, antibody.

Other devices from Biocare Medical, LLC

See all devices from Biocare Medical, LLC →

Properties

  • Prescription use
  • Premarket exempt
  • Lot / batch number
  • Expiration date
Other properties (11, all answered No)